SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-14-000063
Filing Date
2014-11-06
Accepted
2014-11-06 16:02:54
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2014q310-q.htm 10-Q 1406447
2 EXHIBIT 31.1 a2014q310-q_exhibit3111.htm EX-31.1 14513
3 EXHIBIT 31.2 a2014q310-q_exhibit3121.htm EX-31.2 14347
4 EXHIBIT 32.1 a2014q310-q_exhibit3211.htm EX-32.1 11748
  Complete submission text file 0000875320-14-000063.txt   9002420

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrtx-20140930.xml EX-101.INS 1538749
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20140930.xsd EX-101.SCH 52816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20140930_cal.xml EX-101.CAL 88294
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20140930_def.xml EX-101.DEF 190103
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20140930_lab.xml EX-101.LAB 683168
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20140930_pre.xml EX-101.PRE 351103
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 141200600
SIC: 2834 Pharmaceutical Preparations